C N Bagot1, E Leishman2. 1. Department of Haematology, Glasgow Royal Infirmary, Glasgow, UK. Electronic address: catherine.bagot@ggc.scot.nhs.uk. 2. Department of Haematology, Glasgow Royal Infirmary, Glasgow, UK.
Abstract
BACKGROUND: Thrombin generation is a global coagulation assay which appears to be an effective method for assessing the potential for an individual's plasma to coagulate. However for this assay to become accepted in routine clinical practice it requires standardization. OBJECTIVES: To establish a reference range for the NIBSC reference plasma (TGT-RP) which can then become an internal quality control (IQC) for thrombin generation assays. PATIENTS/ METHODS: Thrombin generation was measured in TGT-RP in 153 independent experiments using 4 assay conditions; 1 pM tissue factor (TF) or 5 pM TF +/- thrombomodulin (TM). A target value +/- 2 SD was calculated to provide an acceptance range under the 4 conditions. A plasma sample from a healthy volunteer was subsequently tested in 11 separate experiments using the TGT-RP for (i) normalisation and (ii) exclusion of experimental results when the TGT-RP results did not fall within the established acceptance range. RESULTS: An acceptance range was established for TGT-RP for the 4 assay conditions. Normalisation of all results from a healthy volunteer reduced inter-assay variability significantly (ETP: p=0.0003; Peak: p=0.001). Exclusion of results from the volunteer when concurrently run TGT-RP results fell outside the acceptance range reduced inter-assay variability significantly when reporting raw data (ETP: p=0.001; Peak: p=0.004). However normalisation of this data had no beneficial effect (ETP: p=0.126; Peak: p=0.232). CONCLUSIONS: Our work represents further progress in the standardization of thrombin generation techniques with the establishment of an IQC reference range. Using an IQC reduces inter-assay variability, whilst allowing reporting of raw data and ensures production of accurate and reproducible data.
BACKGROUND:Thrombin generation is a global coagulation assay which appears to be an effective method for assessing the potential for an individual's plasma to coagulate. However for this assay to become accepted in routine clinical practice it requires standardization. OBJECTIVES: To establish a reference range for the NIBSC reference plasma (TGT-RP) which can then become an internal quality control (IQC) for thrombin generation assays. PATIENTS/ METHODS:Thrombin generation was measured in TGT-RP in 153 independent experiments using 4 assay conditions; 1 pM tissue factor (TF) or 5 pM TF +/- thrombomodulin (TM). A target value +/- 2 SD was calculated to provide an acceptance range under the 4 conditions. A plasma sample from a healthy volunteer was subsequently tested in 11 separate experiments using the TGT-RP for (i) normalisation and (ii) exclusion of experimental results when the TGT-RP results did not fall within the established acceptance range. RESULTS: An acceptance range was established for TGT-RP for the 4 assay conditions. Normalisation of all results from a healthy volunteer reduced inter-assay variability significantly (ETP: p=0.0003; Peak: p=0.001). Exclusion of results from the volunteer when concurrently run TGT-RP results fell outside the acceptance range reduced inter-assay variability significantly when reporting raw data (ETP: p=0.001; Peak: p=0.004). However normalisation of this data had no beneficial effect (ETP: p=0.126; Peak: p=0.232). CONCLUSIONS: Our work represents further progress in the standardization of thrombin generation techniques with the establishment of an IQC reference range. Using an IQC reduces inter-assay variability, whilst allowing reporting of raw data and ensures production of accurate and reproducible data.
Authors: Marcus Ljungkvist; Maria Berndtsson; Margareta Holmström; Danijela Mikovic; Ivo Elezovic; Jovan P Antovic; Eva Zetterberg; Erik Berntorp Journal: Mediterr J Hematol Infect Dis Date: 2017-11-01 Impact factor: 2.576
Authors: Karen S Brown; Hamim Zahir; Michael A Grosso; Hans J Lanz; Michele F Mercuri; Jerrold H Levy Journal: Crit Care Date: 2016-09-23 Impact factor: 9.097
Authors: Sara Calzavarini; Justine Brodard; Claudia Quarroz; Livia Maire; Raphael Nützi; Jovana Jankovic; Laura C Rotondo; Evelyne Giabbani; Georg Martin Fiedler; Michael Nagler; Anne Angelillo-Scherrer Journal: Res Pract Thromb Haemost Date: 2019-07-18